Skip to main content
Top
Published in: Journal of Translational Medicine 1/2021

Open Access 01-12-2021 | Fatigue | Research

The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?

Authors: Iñigo Murga, Larraitz Aranburu, Pascual A. Gargiulo, Juan-Carlos Gómez-Esteban, José-Vicente Lafuente

Published in: Journal of Translational Medicine | Issue 1/2021

Login to get access

Abstract

The maintained attention is the cause of great functional limitations in CFS/ME, a disease that mainly affects women in the central period of life. Cognitive function is explored using the Montreal Cognitive Assessment, the maintained attention using the Toulouse-Piéron test with which the Global Index of Attention and Perception (GIAP) is obtained, the fatigue using the visual analog scale and the perception of effort using the modified Borg scale. The final sample were 84 patients (66 women/18 men) who met diagnostic criteria (Fukuda-1994, Carruthers-2011) and 22 healthy controls (14 women/8 men). Most of patients maintain normal cognitive function, showing low or very low attention score in the 70% of patients with a marked cognitive fatigue compared to the control group (p < 0.05). There were no significant differences between genders in GIAP or fatigue for CFS/ME; however, sick women perceive cognitive effort higher than men. Deficits in sustained attention and the perception of fatigue, so effort after performing the proposed test are a sensitive and reliable indicator that allows us to substantiate a clinical suspicion and refer patients for further studies in order to confirm or rule out CFS/ME.
Literature
1.
go back to reference Acheson ED. A new clinical entity? Lancet. 1956;26:789–90. Acheson ED. A new clinical entity? Lancet. 1956;26:789–90.
2.
go back to reference World Health Organization. International Classification of Diseases. 8th Revision ed. Diseases of the nervous system p. 158. (ICD-8); Code 323. Geneva (Switzerland): WHO; 1967. World Health Organization. International Classification of Diseases. 8th Revision ed. Diseases of the nervous system p. 158. (ICD-8); Code 323. Geneva (Switzerland): WHO; 1967.
4.
go back to reference Hyde BM, Goldstein JA, Levine P. The clinical and scientific basis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Ottawa (Ontario, Canadá): Nightingale Research Foundation; 1992. Hyde BM, Goldstein JA, Levine P. The clinical and scientific basis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Ottawa (Ontario, Canadá): Nightingale Research Foundation; 1992.
10.
go back to reference Tudela P. Atención, En J. L. Fernández- Trespalacios y P. Tudela (Coords.), Atención y percepción. Vol. 3 (pp. 119–163). En J. Mayory, J. L. Pinillos (Eds.), Tratado de Psicología General. Madrid: Alhambra; 1992. Tudela P. Atención, En J. L. Fernández- Trespalacios y P. Tudela (Coords.), Atención y percepción. Vol. 3 (pp. 119–163). En J. Mayory, J. L. Pinillos (Eds.), Tratado de Psicología General. Madrid: Alhambra; 1992.
12.
go back to reference Lozano M, Hernández M, Turró O, Pericot I, López-Pousa S, Vilalta J. Validación del Montreal Cognitive Assessment (MOCA): test de cribado para el deterioro cognitivo leve Datos preliminares. Alzheimer Real Invet Demenc. 2009;43:4–11. Lozano M, Hernández M, Turró O, Pericot I, López-Pousa S, Vilalta J. Validación del Montreal Cognitive Assessment (MOCA): test de cribado para el deterioro cognitivo leve Datos preliminares. Alzheimer Real Invet Demenc. 2009;43:4–11.
13.
go back to reference Morales M, Sosa MA, Quattrocchio L. Estudio de la confiabilidad de la prueba Toulouse-Piéron (versión 6ª edición revisada). Diagnosis. 2014;11:9. Morales M, Sosa MA, Quattrocchio L. Estudio de la confiabilidad de la prueba Toulouse-Piéron (versión 6ª edición revisada). Diagnosis. 2014;11:9.
14.
go back to reference Yela M, Dpto de I+D+I de TEA ediciones. Toulouse-Piéron-Revisado, prueba perceptiva y de atención. 8ª edición. Madrid: TEA ediciones; 2013. Yela M, Dpto de I+D+I de TEA ediciones. Toulouse-Piéron-Revisado, prueba perceptiva y de atención. 8ª edición. Madrid: TEA ediciones; 2013.
16.
go back to reference Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med. 1970;2:92–8.PubMed Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med. 1970;2:92–8.PubMed
18.
go back to reference Kitani T. Term Commitee of Japanese Society of Fatigue Science. Nihon Hirougakkaishi (In Japanese). 2011;6(2):1. Kitani T. Term Commitee of Japanese Society of Fatigue Science. Nihon Hirougakkaishi (In Japanese). 2011;6(2):1.
19.
go back to reference Mathew SJ, Mao X, Keegan KA, Levine SM, Smith EL, Heier LA, et al. Ventricular cerebrospinal fluid lactate is increased in Chronic Fatigue Syndrome compared with generalized anxiety disorder: an in vivo 3.0 T (1)H MRS imaging study. NMR Biomed. 2009;22(3):251–8. https://doi.org/10.1002/nbm.1315.CrossRefPubMed Mathew SJ, Mao X, Keegan KA, Levine SM, Smith EL, Heier LA, et al. Ventricular cerebrospinal fluid lactate is increased in Chronic Fatigue Syndrome compared with generalized anxiety disorder: an in vivo 3.0 T (1)H MRS imaging study. NMR Biomed. 2009;22(3):251–8. https://​doi.​org/​10.​1002/​nbm.​1315.CrossRefPubMed
24.
go back to reference Chen C. Neurometabolites in anterior cingulate cortex in Chronic Fatigue Syndrome: A magnetic resonance spectroscopy study at 7 Tesla [Master Thesis]. Oxford: University of Oxford (Department of Psychiatry); 2017. p. 49. Chen C. Neurometabolites in anterior cingulate cortex in Chronic Fatigue Syndrome: A magnetic resonance spectroscopy study at 7 Tesla [Master Thesis]. Oxford: University of Oxford (Department of Psychiatry); 2017. p. 49.
30.
Metadata
Title
The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?
Authors
Iñigo Murga
Larraitz Aranburu
Pascual A. Gargiulo
Juan-Carlos Gómez-Esteban
José-Vicente Lafuente
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Fatigue
Published in
Journal of Translational Medicine / Issue 1/2021
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-021-03153-1

Other articles of this Issue 1/2021

Journal of Translational Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.